介酶干细胞衍生的外体细胞:改善喘呼吸道改造的新希望
Rui Suo1,2, Tianxu Hao1,2, Ruxianguli Wumaier1,2
1Chest Hospital, Tianjin University, Tianjin, China.
Annals of medicine
|November 27, 2025
概括
介质干细胞衍生的外体细胞 (MSC-EXOs) 通过减少呼吸道重塑来治疗喘. 对MSC-EXO的进一步研究可能会为喘患者带来新的再生医学选择.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 肺部病理学 肺部病理学
背景情况:
- 喘是一种慢性呼吸道疾病,其特点是气道过度反应和重塑.
- 喘发病率和死亡率的上升是一个重大的全球卫生挑战.
- 介质干细胞衍生的外体细胞 (MSC-EXOs) 已经成为喘的潜在治疗途径.
研究的目的:
- 综合审查MSC-EXO在缓解喘相关气道改造方面的应用和机制.
- 探索MSC-EXO作为喘管理治疗策略的可行性.
- 确定喘中MSC-EXO治疗的局限性和未来研究方向.
主要方法:
- 通过使用关键词进行了系统的文献审查:喘,气道改造,介质细胞干细胞和外体细胞.
- 在PubMed,Embase和Web of Science进行了对2000年3月17日至2024年9月24日期间发表的研究的搜索.
- 分析了获取的研究,以提供MSC-EXOs在喘中的全面概述.
主要成果:
- 该综述考察了喘病原,当前的治疗方法及其局限性.
- 它详细介绍了MSCs和MSC-EXOs在通过特定的分子机制减少气道改造方面的作用.
- 确定了MSC-EXO疗法的当前研究局限性和未来研究途径.
结论:
- 作为喘再生医学中的治疗方法,MSC-EXOs提供了优势.
- 临床前研究始终表明MSC-EXOs在喘中的治疗潜力.
- 未来,MSC-EXOs可能会为喘患者提供新的治疗选择.
相关概念视频
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K


